fingolimod hydrochloride has been researched along with B16 Melanoma in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 6 (85.71) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, J; Haeryfar, SMM; Lesage, S; Rudak, PT | 1 |
Niedermann, G; Zhang, X | 1 |
Arruda, DC; Bueno, V; Figueiredo, CR; Massaoka, MH; Matsuo, AL; Pereira, FV; Rodrigues, EG | 1 |
Arlt, O; Danciu, C; Dehelean, C; Neske, C; Pfarr, K; Pfeilschifter, JM; Radeke, HH | 1 |
Chen, G; Feng, J; Guo, R; Han, G; Hou, C; Li, Y; Lv, Z; Ma, Y; Morris, JC; Ning, C; Shen, B; Taylor, EN; Wang, R; Wang, Y; Xiao, H; Zhou, T | 1 |
Engelhard, VH; Enriquez, HL; Fu, YX; Thompson, ED | 1 |
Billy, E; Butler, J; Hla, T; LaMontagne, K; Liau, G; Littlewood-Evans, A; O'Reilly, T; Probst, B; Sanchez, T; Schnell, C; Theuer, A; Wood, A; Wood, J; Wyder, L | 1 |
7 other study(ies) available for fingolimod hydrochloride and B16 Melanoma
Article | Year |
---|---|
Glycolipid Stimulation of Invariant NKT Cells Expands a Unique Tissue-Resident Population of Precursors to Mature NK Cells Endowed with Oncolytic and Antimetastatic Properties.
Topics: Animals; Antigens, Neoplasm; Cell Line, Tumor; Fingolimod Hydrochloride; Galactosylceramides; Immunotherapy; Interleukin-12; Interleukin-18; Killer Cells, Natural; Melanoma, Experimental; Mice; Mice, Knockout; Natural Killer T-Cells; Neoplasm Metastasis; Sphingosine-1-Phosphate Receptors; Thymoma | 2019 |
Abscopal Effects With Hypofractionated Schedules Extending Into the Effector Phase of the Tumor-Specific T-Cell Response.
Topics: Animals; Antibodies; CD8-Positive T-Lymphocytes; Combined Modality Therapy; Fingolimod Hydrochloride; Flow Cytometry; Humans; Immunosuppressive Agents; Immunotherapy, Adoptive; Interferon-gamma; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Programmed Cell Death 1 Receptor; Radiation Dose Hypofractionation; Relative Biological Effectiveness | 2018 |
FTY720 induces apoptosis in B16F10-NEX2 murine melanoma cells, limits metastatic development in vivo, and modulates the immune system.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Caspase 3; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Fingolimod Hydrochloride; Flow Cytometry; Humans; Immunosuppressive Agents; Lung Neoplasms; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Microscopy, Electron, Transmission; Propylene Glycols; Reactive Oxygen Species; Sphingosine; Time Factors | 2013 |
Simultaneous and dose dependent melanoma cytotoxic and immune stimulatory activity of betulin.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Fingolimod Hydrochloride; Genistein; Melanoma, Experimental; Mice, Inbred C57BL; Neoplasm Transplantation; T-Lymphocytes; Triterpenes | 2015 |
The protumorigenic potential of FTY720 by promoting extramedullary hematopoiesis and MDSC accumulation.
Topics: Animals; Cell Growth Processes; Cell Line, Tumor; Colonic Neoplasms; Fingolimod Hydrochloride; Hematopoiesis, Extramedullary; Humans; Immunosuppressive Agents; Male; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Myeloid Cells; Tumor Microenvironment | 2017 |
Tumor masses support naive T cell infiltration, activation, and differentiation into effectors.
Topics: Adoptive Transfer; Animals; Antigen Presentation; Antigen-Presenting Cells; beta 2-Microglobulin; Carcinoma, Lewis Lung; CD11a Antigen; CD8-Positive T-Lymphocytes; Cell Differentiation; Cell Movement; Cell Proliferation; DNA-Binding Proteins; Fingolimod Hydrochloride; Granzymes; Hyaluronan Receptors; Immunosuppressive Agents; Integrin alpha4; Interferon-gamma; Lymph Nodes; Lymphocyte Activation; Lysosomal Membrane Proteins; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Monophenol Monooxygenase; Neoplasms; Ovalbumin; Peptide Fragments; Propylene Glycols; Receptors, Antigen, T-Cell; Sphingosine; T-Lymphocyte Subsets | 2010 |
Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization.
Topics: Animals; Calcium; Cell Growth Processes; Cell Movement; Cornea; Endothelial Cells; Female; Fingolimod Hydrochloride; Humans; Melanoma, Experimental; Mice; Mitogen-Activated Protein Kinases; Neovascularization, Pathologic; Neovascularization, Physiologic; Phosphorylation; Phthalazines; Propylene Glycols; Pyridines; Receptors, Lysosphingolipid; Sphingosine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2006 |